Business Description
Nectar Lifesciences Ltd
ISIN : US63975T1051
Share Class Description:
LUX:NECLF: ADRCompare
Compare
Traded in other countries / regions
532649.IndiaNECLF.Luxembourg IPO Date
2010-01-03Description
Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company's product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 3.51 | |||||
| Interest Coverage | 1.24 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.62 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3 | |||||
| 3-Year EBITDA Growth Rate | 40.2 | |||||
| 3-Year Book Growth Rate | 0.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 33.19 | |||||
| 6-1 Month Momentum % | -10.95 | |||||
| 12-1 Month Momentum % | -1.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 189.43 | |||||
| Days Sales Outstanding | 76.73 | |||||
| Days Payable | 105.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 9.17 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 19.39 | |||||
| Operating Margin % | 6.72 | |||||
| Net Margin % | 0.64 | |||||
| FCF Margin % | 11.68 | |||||
| ROE % | 1 | |||||
| ROA % | 0.49 | |||||
| ROIC % | 2.56 | |||||
| ROC (Joel Greenblatt) % | 8.26 | |||||
| ROCE % | 9.7 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 88.17 | |||||
| PE Ratio without NRI | 88.17 | |||||
| Shiller PE Ratio | 25.71 | |||||
| Price-to-Owner-Earnings | 9.26 | |||||
| PS Ratio | 0.56 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 0.9 | |||||
| Price-to-Free-Cash-Flow | 4.76 | |||||
| Price-to-Operating-Cash-Flow | 4.14 | |||||
| EV-to-EBIT | 12.94 | |||||
| EV-to-EBITDA | 8.54 | |||||
| EV-to-Revenue | 0.91 | |||||
| EV-to-FCF | 7.85 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Graham-Number | 1.88 | |||||
| Price-to-Net-Current-Asset-Value | 4.48 | |||||
| Earnings Yield (Greenblatt) % | 7.73 | |||||
| FCF Yield % | 21.01 | |||||
| Forward Rate of Return (Yacktman) % | 8.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nectar Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 201.353 | ||
| EPS (TTM) ($) | 0.006 | ||
| Beta | 1.29 | ||
| Volatility % | 34.27 | ||
| 14-Day RSI | 33.19 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.358 | ||
| 12-1 Month Momentum % | -1.1 | ||
| 52-Week Range ($) | 0.348 - 0.54 | ||
| Shares Outstanding (Mil) | 224.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nectar Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nectar Lifesciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nectar Lifesciences Ltd Frequently Asked Questions
What is Nectar Lifesciences Ltd(LUX:NECLF)'s stock price today?
The current price of LUX:NECLF is $0.36. The 52 week high of LUX:NECLF is $0.54 and 52 week low is $0.35.
When is next earnings date of Nectar Lifesciences Ltd(LUX:NECLF)?
The next earnings date of Nectar Lifesciences Ltd(LUX:NECLF) is .
Does Nectar Lifesciences Ltd(LUX:NECLF) pay dividends? If so, how much?
Nectar Lifesciences Ltd(LUX:NECLF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers